Invention Grant
US09399046B2 Treatment of CNS disorders using descendants of MSCs expressing an exogenous Notch intracellular domain
有权
使用表达外源性Notch细胞内结构域的MSC的后代治疗CNS紊乱
- Patent Title: Treatment of CNS disorders using descendants of MSCs expressing an exogenous Notch intracellular domain
- Patent Title (中): 使用表达外源性Notch细胞内结构域的MSC的后代治疗CNS紊乱
-
Application No.: US13733510Application Date: 2013-01-03
-
Publication No.: US09399046B2Publication Date: 2016-07-26
- Inventor: Mari Dezawa , Hajime Sawada , Hiroshi Kanno , Masahiko Takano
- Applicant: SanBio, Inc.
- Applicant Address: US CA Mountain View
- Assignee: SanBio, Inc.
- Current Assignee: SanBio, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Levine Bagade Han LLP
- Priority: JP2002-030003 20020206
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C12N5/02 ; A61K35/28 ; C12N5/0793 ; C12N5/077 ; A61K9/00 ; C12N5/079 ; A61K35/12 ; C12N5/0775

Abstract:
There is provided a method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of a Notch gene. Specifically, the invention provides a method of inducing differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells in vitro, which method comprises introducing a Notch gene and/or a Notch signaling related gene into the cells, wherein the finally obtained differentiated cells are the result of cell division of the bone marrow stromal cells into which the Notch gene and/or Notch signaling related gene have been introduced. The invention also provides a method of inducing further differentiation of the differentiation-induced neural cells to dopaminergic neurons or acetylcholinergic neurons. The invention yet further provides a treatment method for neurodegenerative and skeletal muscle degenerative diseases which employs neural precursor cells, neural cells or skeletal muscle cells produced by the method of the invention.
Public/Granted literature
Information query